ENAM

gene
On this page

Summary

ENAM (enamelin, HGNC:3344) is a protein-coding gene on chromosome 4q13.3, encoding Enamelin (Q9NRM1). Involved in the mineralization and structural organization of enamel.

Dental enamel forms the outer cap of teeth and is the hardest substance found in vertebrates. This gene encodes the largest protein in the enamel matrix of developing teeth. The protein is involved in the mineralization and structural organization of enamel. Defects in this gene result in amelogenesis imperfect type 1C.

Source: NCBI Gene 10117 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): amelogenesis imperfecta type 1B (Definitive, GenCC) — +2 more curated relationships
  • GWAS associations: 1
  • Clinical variants (ClinVar): 305 total — 8 pathogenic, 3 likely-pathogenic
  • Phenotypes (HPO): 7
  • MANE Select transcript: NM_031889

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:3344
Approved symbolENAM
Nameenamelin
Location4q13.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000132464
Ensembl biotypeprotein_coding
OMIM606585
Entrez10117

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000396073, ENST00000472597

RefSeq mRNA: 1 — MANE Select: NM_031889 NM_031889

CCDS: CCDS3544

Canonical transcript exons

ENST00000396073 — 9 exons

ExonStartEnd
ENSE000008509957064201570646824
ENSE000009043827063167070631738
ENSE000009043837063184970631893
ENSE000009043847063265170632692
ENSE000009043857063430870634568
ENSE000009043867063583270635894
ENSE000009043877063779070637843
ENSE000015237687062944170629554
ENSE000015237707062874470628964

Expression profiles

Bgee: expression breadth broad, 83 present calls, max score 89.87.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1428 / max 16.4209, expressed in 56 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
479880.142856

Top tissues by expression

209 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ventricle myocardiumUBERON:000656689.87gold quality
cardiac muscle of right atriumUBERON:000337989.06gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.45gold quality
kidney epitheliumUBERON:000481983.73silver quality
islet of LangerhansUBERON:000000681.84gold quality
vastus lateralisUBERON:000137976.01silver quality
quadriceps femorisUBERON:000137775.34silver quality
epithelial cell of pancreasCL:000008374.13gold quality
biceps brachiiUBERON:000150772.94silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450272.51gold quality
skeletal muscle tissueUBERON:000113472.30gold quality
muscle tissueUBERON:000238571.99gold quality
adult mammalian kidneyUBERON:000008271.69gold quality
deltoidUBERON:000147669.72silver quality
corpus epididymisUBERON:000435969.07gold quality
kidneyUBERON:000211369.03gold quality
buccal mucosa cellCL:000233668.67gold quality
pancreasUBERON:000126468.10gold quality
colonic epitheliumUBERON:000039767.47silver quality
gall bladderUBERON:000211067.40gold quality
hindlimb stylopod muscleUBERON:000425266.77gold quality
superficial temporal arteryUBERON:000161466.53gold quality
heart right ventricleUBERON:000208066.20gold quality
gingival epitheliumUBERON:000194965.97gold quality
muscle of legUBERON:000138365.75gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451165.70silver quality
gastrocnemiusUBERON:000138865.47gold quality
heart left ventricleUBERON:000208465.45gold quality
cardiac ventricleUBERON:000208265.44gold quality
cortex of kidneyUBERON:000122564.94gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.13

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CTNNB1, LEF1, SP3

miRNA regulators (miRDB)

115 targeting ENAM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-340-5P100.0072.504437
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-607799.9968.042299
HSA-MIR-366299.9973.825684
HSA-MIR-34A-5P99.9971.211784
HSA-MIR-449A99.9971.051776
HSA-MIR-450099.9972.722367
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-548P99.9872.253784
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-34C-5P99.9770.451577
HSA-MIR-449B-5P99.9770.261580
HSA-MIR-314899.9775.066478
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-211099.9666.681930
HSA-MIR-548AT-5P99.9670.832666

Literature-anchored findings (GeneRIF, showing 32)

  • A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (PMID:11978766)
  • heterogeneous mutations are responsible for an autosomal-dominant hypoplastic form of amelogenesis imperfecta (PMID:12407086)
  • critical for proper dental enamel formation (PMID:14656895)
  • Demonstration of a ENAM mutation responsible for autosomal recessive amelogenesis imperfecta and localised enamel pitting. (PMID:14684688)
  • Ultrastructural enamel changes in the patient with the autosomal dominant ENAM g.13185-13186insAG mutation, were less pronounced compared to ultrastructural changes in patients with the autosomal dominant ENAM mutation 8344delG. (PMID:17125728)
  • A mutation was found in exon 9 where guanine was substituted by thymine in one of the alleles in position 817, generating a change of arginine to methionine in codon 179 of the protein. (PMID:17316551)
  • This work shows that bursts of adaptive enamelin evolution occur on primate lineages with inferred dietary changes. (PMID:18245370)
  • a single base difference g359A –> G located in exon 1 was identified and ruled out the possible mutation in exon 2, exon 3, exon 4, exon 5, exon 6, exon 7, exon 8, exon 9, exon 10, g2382, g6395 and g8344 of ENAM gene in the AI patient. (PMID:18466877)
  • A total of 463 individuals from 54 families were evaluated and mutations in the AMEL, ENAM and KLK4 genes were identified. (PMID:18714142)
  • Analysis revealed 2 ENAM mutations (autosomal-dominant g.14917delT and autosomal-recessive g.13185-13186insAG mutations). Single T deletion in exon 10 is a novel deletion mutation(g.14917delT, c.2991delT)predicted to result in premature termination codon. (PMID:19329462)
  • The structure and composition of deciduous enamel affected by local hypoplastic autosomal dominant amelogenesis imperfecta resulting from an ENAM mutation (PMID:19923784)
  • hypocalcified amelogenesis imperfecta, Witkop type III, was unrelated to previously described mutations in the ENAM or MMP-20 genes (PMID:21504268)
  • Mutations in FAM83H and ENAM and related phenotypes were observed in Chinese families with amelogenesis imperfecta. (PMID:22414746)
  • Associations between TFIP11 (p=0.02), ENAM (p=0.00001), and AMELX (p=0.01) could be seen with caries independent of having MIH or genomic DNA copies of Streptococcus mutans detected by real time PCR in the Brazilian sample. (PMID:23790503)
  • 2 exonic SNPs, both changing an amino acid in protein region encoded by exon 10 (p.I648T and p.R763Q), increased caries susceptibility 2.66-fold. findings support ENAM as gene candidate for caries susceptibility. (PMID:24487377)
  • Whole-exome sequencing identified 2 novel heterozygous nonsense mutations in the ENAM gene (c.454G>T p.Glu152* in family 1, c.358C>T p.Gln120* in family 2) in the probands. Affected individuals were heterozygous for the mutation in each family. (PMID:25143514)
  • findings provide useful information for the implication of ENAM gene polymorphism in autosomal-dominant/-recessive amelogenesis imperfecta. (PMID:25427323)
  • Screening of ENAM and LAMB3 genes was performed by direct sequencing of genomic DNA from blood samples. (PMID:25769099)
  • Overrepresentation of the G allele of the enamelin marker was seen in the erosion group compared to the unaffected group. (PMID:25791822)
  • The study revealed the strong association between rs12640848 marker of ENAM gene and caries susceptibility in primary teeth in children from Poland. (PMID:26910531)
  • study investigated the phenotypic effect of SNP C14625T (rs7671281) on the thickness of human dental enamel, exploring the effects of positive selection on a dental gene (PMID:27357321)
  • The ENAM and TNF-alpha genes were likely associated with caries occurrence in Chinese children. The ENAM rs3796703 CT and TNF-alpha rs1800629 AG genotypes might be involved in caries susceptibility and protection, respectively. (PMID:28395167)
  • Among the variants shared with modern humans, two are ancestral (common with apes) and one is the derived enamelin major variant, T648I (rs7671281), associated with a thinner enamel and specific to the Homo lineage. (PMID:28902892)
  • Lack of association between the ENAM polymorphism (rs12640848) and dental caries in Czech children was detected. (PMID:29185146)
  • An ENAM nonsense mutation identified in a family with hypoplastic amelogenesis imperfecta resulted in a highly variable clinical phenotype in individuals with a heterozygous mutant allele. (PMID:29554435)
  • Two novel ENAM frameshift mutations were identified. A single-nucleotide duplication replaced amino acids 133-1142 with a 12 amino acid sequence, and a single-nucleotide deletion replaced amino acids 921-1142 with 31 amino acids (ESSPQQASYQAKETAQRRGKAKTLLEMMCPR*). (PMID:31478359)
  • ENAM Gene Variation in Students Exposed to Different Fluoride Concentrations. (PMID:32178265)
  • ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma. (PMID:33539322)
  • A novel ENAM mutation causes hypoplastic amelogenesis imperfecta. (PMID:33864320)
  • Splicing mutations in AMELX and ENAM cause amelogenesis imperfecta. (PMID:37985977)
  • Genetic variations in exon 10 of ENAM and their association with early childhood caries. (PMID:38642606)
  • ENAM Mutations Can Cause Hypomaturation Amelogenesis Imperfecta. (PMID:38716742)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusEnamENSMUSG00000029286
rattus_norvegicusEnamENSRNOG00000003672

Protein

Protein identifiers

EnamelinQ9NRM1 (reviewed: Q9NRM1)

All UniProt accessions (2): Q9NRM1, A0A3B3ITB9

UniProt curated annotations — full annotation on UniProt →

Function. Involved in the mineralization and structural organization of enamel. Involved in the extension of enamel during the secretory stage of dental enamel formation.

Subcellular location. Secreted. Extracellular space. Extracellular matrix.

Tissue specificity. Expressed in tooth particularly in odontoblast, ameloblast and cementoblast.

Post-translational modifications. Phosphorylated by FAM20C in vitro.

Disease relevance. Amelogenesis imperfecta 1B (AI1B) [MIM:104500] An autosomal dominant defect of enamel formation. Clinical manifestations may be variable. Some cases present with generalized enamel hypoplasia resulting in small, smooth, yellow and widely spaced teeth (smooth hypoplastic AI). Others show horizontal rows of pits, grooves or a hypoplastic area in the enamel (local hypoplastic AI). The disease is caused by variants affecting the gene represented in this entry. Amelogenesis imperfecta 1C (AI1C) [MIM:204650] An autosomal recessive defect of dental enamel formation. Teeth show local hypoplastic and unmineralized enamel, and a yellow-brown discoloration. Enamel defects can be associated with facial and oral features including vertical dysgnathia and anterior openbite malocclusion. The disease is caused by variants affecting the gene represented in this entry.

RefSeq proteins (1): NP_114095* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR015673EnamelinFamily

Pfam: PF15362

UniProt features (45 total): compositionally biased region 15, glycosylation site 10, region of interest 6, sequence variant 6, sequence conflict 3, modified residue 2, signal peptide 1, chain 1, mutagenesis site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NRM1-F136.630.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 191, 216

Glycosylation sites (10): 114, 126, 245, 252, 265, 296, 467, 534, 934, 1040

Mutagenesis-validated functional residues (1):

PositionPhenotype
191decreased phosphorylation by fam20c.

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-381426Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
R-HSA-8957275Post-translational protein phosphorylation

MSigDB gene sets: 110 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, GOBP_TOOTH_MINERALIZATION, chr4q13, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_ENAMEL_MINERALIZATION, GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, WTGAAAT_UNKNOWN, GOBP_AMELOGENESIS, GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION, POU3F2_02, GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, GOBP_ODONTOGENESIS, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, YATGNWAAT_OCT_C

GO Biological Process (4): biomineral tissue development (GO:0031214), ameloblast differentiation (GO:0036305), positive regulation of enamel mineralization (GO:0070175), amelogenesis (GO:0097186)

GO Molecular Function (2): structural constituent of tooth enamel (GO:0030345), protein binding (GO:0005515)

GO Cellular Component (3): endoplasmic reticulum lumen (GO:0005788), extracellular matrix (GO:0031012), extracellular region (GO:0005576)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Metabolism of proteins1
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
tissue development1
animal organ development1
columnar/cuboidal epithelial cell differentiation1
enamel mineralization1
positive regulation of tooth mineralization1
regulation of enamel mineralization1
odontogenesis of dentin-containing tooth1
anatomical structure formation involved in morphogenesis1
extracellular matrix structural constituent conferring compression resistance1
binding1
endoplasmic reticulum1
intracellular organelle lumen1
external encapsulating structure1
cellular anatomical structure1

Protein interactions and networks

STRING

990 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ENAMAMBNQ9NP70999
ENAMAMTNQ6UX39993
ENAMAMELXQ99217985
ENAMTUFT1Q9NNX1981
ENAMDSPPQ9NZW4899
ENAMMMP20O60882888
ENAMODAMA1E959855
ENAMKLK4Q9Y5K2836
ENAMSACK1HQ6ZRV2811
ENAMAMELYQ99218798
ENAMWDR72Q3MJ13788
ENAMODAPHQ17RF5773
ENAMACP4Q9BZG2717
ENAMMMP25Q9NPA2717
ENAMDMP1Q13316710

IntAct

5 interactions, top by confidence:

ABTypeScore
FAM20CENAMpsi-mi:“MI:0217”(phosphorylation reaction)0.440
ENAMFAM20Cpsi-mi:“MI:0217”(phosphorylation reaction)0.440
ENAMNCLpsi-mi:“MI:0915”(physical association)0.400
NEK4E2F8psi-mi:“MI:0914”(association)0.350

BioGRID (6): ENAM (Proximity Label-MS), ENAM (Affinity Capture-MS), ENAM (Affinity Capture-MS), ENAM (Cross-Linking-MS (XL-MS)), ENAM (Proximity Label-MS), ENAM (Affinity Capture-RNA)

ESM2 similar proteins: A0A0J9YXV3, A0A172M4N0, A2VE23, A5PL33, C7EMF5, E7EW31, F1NSM7, I3L273, O15027, O48582, O55189, O55196, O97939, P0C671, P0DV77, P14138, Q14D33, Q1XI13, Q28989, Q3B7M4, Q4R729, Q5R7U0, Q5SWP3, Q62840, Q63003, Q6E0U4, Q6H236, Q6NUN9, Q6UXA7, Q7Z2K8, Q86UU5, Q8BM15, Q8K4E0, Q8K4L6, Q8N1P7, Q8N3D4, Q96D09, Q96JG9, Q9BGL9, Q9D7G9

Diamond homologs: O55196, O97939, Q9NRM1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

305 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic8
Likely pathogenic3
Uncertain significance231
Likely benign22
Benign25

Top pathogenic / likely-pathogenic (11)

Variant IDHGVSClassification
1012267NM_031889.3(ENAM):c.-61+1G>APathogenic
1192504NM_031889.3(ENAM):c.588+1delPathogenic
2445233NM_031889.3(ENAM):c.664C>T (p.Gln222Ter)Pathogenic
4236NM_031889.3(ENAM):c.534+1G>APathogenic
4237NM_031889.3(ENAM):c.157A>T (p.Lys53Ter)Pathogenic
4813874NM_031889.3(ENAM):c.1083G>A (p.Trp361Ter)Pathogenic
488662NM_031889.3(ENAM):c.1842C>G (p.Tyr614Ter)Pathogenic
517662NM_031889.3(ENAM):c.123+2T>GPathogenic
2440040NM_031889.3(ENAM):c.372_382del (p.Lys124fs)Likely pathogenic
2628824NM_031889.3(ENAM):c.107del (p.Asn36fs)Likely pathogenic
2690595NM_031889.3(ENAM):c.935_944del (p.Ser312fs)Likely pathogenic

SpliceAI

989 predictions. Top by Δscore:

VariantEffectΔscore
4:70631735:GCCA:Gdonor_gain1.0000
4:70631739:G:GGdonor_gain1.0000
4:70632645:TTGCA:Tacceptor_loss1.0000
4:70632646:TGCA:Tacceptor_loss1.0000
4:70632647:GCA:Gacceptor_loss1.0000
4:70632648:CA:Cacceptor_loss1.0000
4:70632649:A:AGacceptor_gain1.0000
4:70632649:AGAT:Aacceptor_gain1.0000
4:70632650:G:GGacceptor_gain1.0000
4:70632650:GAT:Gacceptor_gain1.0000
4:70632650:GATG:Gacceptor_gain1.0000
4:70632690:CATGT:Cdonor_loss1.0000
4:70632693:G:GGdonor_gain1.0000
4:70632693:GTAA:Gdonor_loss1.0000
4:70632694:T:TCdonor_loss1.0000
4:70632695:AAGT:Adonor_loss1.0000
4:70634303:TTCA:Tacceptor_loss1.0000
4:70634306:A:AGacceptor_gain1.0000
4:70634306:A:Tacceptor_loss1.0000
4:70634306:AGAT:Aacceptor_gain1.0000
4:70634307:G:GAacceptor_loss1.0000
4:70634307:G:GGacceptor_gain1.0000
4:70634307:GAT:Gacceptor_gain1.0000
4:70634307:GATG:Gacceptor_gain1.0000
4:70635826:CTCTA:Cacceptor_loss1.0000
4:70635827:TCTAG:Tacceptor_loss1.0000
4:70635828:CTAGG:Cacceptor_loss1.0000
4:70635829:TAG:Tacceptor_loss1.0000
4:70635830:A:AGacceptor_gain1.0000
4:70635830:A:Gacceptor_loss1.0000

AlphaMissense

7576 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:70631879:A:CS52R0.987
4:70631881:T:AS52R0.987
4:70631881:T:GS52R0.987
4:70631885:A:CS54R0.987
4:70631887:T:AS54R0.987
4:70631887:T:GS54R0.987
4:70631873:T:CF50L0.986
4:70631875:T:AF50L0.986
4:70631875:T:GF50L0.986
4:70631892:A:TE56V0.980
4:70631889:A:TE55V0.978
4:70637826:A:CS191R0.978
4:70637828:C:AS191R0.978
4:70637828:C:GS191R0.978
4:70642024:T:CF200L0.976
4:70642026:T:AF200L0.976
4:70642026:T:GF200L0.976
4:70631891:G:AE56K0.975
4:70631886:G:TS54I0.968
4:70631883:A:TK53I0.967
4:70631880:G:TS52I0.965
4:70642057:C:AR211S0.963
4:70642033:T:CF203L0.959
4:70642035:T:AF203L0.959
4:70642035:T:GF203L0.959
4:70642084:T:CF220L0.959
4:70642086:T:AF220L0.959
4:70642086:T:GF220L0.959
4:70632669:T:CF63L0.956
4:70632671:C:AF63L0.956

dbSNP variants (sampled 300 via entrez): RS1000010635 (4:70627648 T>A), RS1000035921 (4:70631287 G>A), RS1000071270 (4:70627287 C>T), RS1000080815 (4:70626893 A>T), RS1000185100 (4:70641130 T>C), RS1000237270 (4:70641380 A>G,T), RS1000495167 (4:70645855 G>C), RS1000531546 (4:70634231 G>A,C,T), RS1000743168 (4:70627976 C>T), RS1000768767 (4:70646424 C>T), RS1001222404 (4:70646063 T>G), RS1001399631 (4:70633282 C>A), RS1001450653 (4:70630780 C>A,T), RS1001457515 (4:70640399 G>A), RS1001850986 (4:70632917 G>A)

Disease associations

OMIM: gene MIM:606585 | disease phenotypes: MIM:104500, MIM:204650

GenCC curated gene-disease

DiseaseClassificationInheritance
amelogenesis imperfecta type 1BDefinitiveAutosomal dominant
amelogenesis imperfecta type 1CStrongAutosomal recessive
amelogenesis imperfecta type 1StrongSemidominant

Mondo (4): amelogenesis imperfecta (MONDO:0019507), amelogenesis imperfecta type 1B (MONDO:0007092), amelogenesis imperfecta type 1C (MONDO:0008770), amelogenesis imperfecta type 1 (MONDO:0015047)

Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)

HPO phenotypes

7 total (7 of 7 shown, HPO-id order):

HPOTerm
HP:0000006Autosomal dominant inheritance
HP:0000007Autosomal recessive inheritance
HP:0000679Taurodontia
HP:0000705Amelogenesis imperfecta
HP:0006285Enamel hypomineralization
HP:0006286Yellow-brown discoloration of the teeth
HP:0009102Anterior open-bite malocclusion

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009531_3Body fat percentage5.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007800body fat percentage

MeSH disease descriptors (3)

DescriptorNameTree numbers
D000567Amelogenesis ImperfectaC07.650.800.295.250; C07.793.700.295.250; C16.131.850.800.295.250
C562879Amelogenesis Imperfecta, Type IB (supp.)
C567147Amelogenesis Imperfecta, Type Ic (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation1
cupric chlorideaffects expression1
Fulvestrantaffects cotreatment, increases methylation1
Benzo(a)pyreneincreases methylation1
Doxorubicindecreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

8 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01746121Not specifiedTERMINATEDAmelogenesis Imperfecta
NCT02994862Not specifiedUNKNOWNE. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent
NCT03810859Not specifiedUNKNOWNNon-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants
NCT04704089Not specifiedRECRUITINGColorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects
NCT04897724Not specifiedUNKNOWNClinical Performance of Composites in Patients With Amelogenesis Imperfecta
NCT04927962Not specifiedCOMPLETEDPsycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta
NCT05343247Not specifiedCOMPLETEDDental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
NCT07250906Not specifiedRECRUITINGOral Health Related Quality of Life of Children With Amelogenesis Imperfecta